Etiology and Management of Epididymo‑orchitis in Men ≥ 60 years

Primary Etiologic Agents

• Gram‑negative enteric bacteria, especially Escherichia coli, are the predominant cause of epididymo‑orchitis in men ≥ 60 years, typically linked to urinary‑tract infection, bladder outlet obstruction, or recent urinary instrumentation. [CDC 1, 2, 3]
• Enteric‑origin infections arise from urinary‑tract sources rather than sexually transmitted pathogens. [CDC 1, 2, 3]

Predisposing Factors

• Recent urinary‑tract instrumentation or surgery markedly increases the risk of enteric‑origin epididymo‑orchitis. [CDC 1]
• Anatomical urinary‑tract abnormalities (e.g., strictures, congenital malformations, obstruction) predispose older men to infection. [CDC 1]
• Indwelling urinary catheters can introduce enteric organisms; however, cultures from long‑term catheters often reflect colonization rather than true infection. [Infectious Diseases Society of America 4]

Less Common but Clinically Important Pathogens

• Tuberculous epididymitis should be considered when symptoms persist despite standard antibacterial therapy, particularly in immunocompromised patients or those with tuberculosis risk factors. [Infectious Diseases Society of America 4, CDC 5]
• Fungal epididymitis may occur in immunosuppressed individuals (e.g., HIV infection, diabetes, chronic immunosuppressive therapy). [Infectious Diseases Society of America 4, CDC 5]
• Systemic fungal diseases such as blastomycosis, histoplasmosis, and coccidioidomycosis can involve the epididymis or testis. [Infectious Diseases Society of America 4]

Clinical Presentation & Diagnostic Considerations

• Sexually transmitted pathogens (Chlamydia trachomatis, Neisseria gonorrhoeae) are uncommon in men ≥ 60 years unless the patient remains sexually active with new partners. [CDC 1, 2]
• Urethritis is typically absent in enteric‑origin epididymo‑orchitis, distinguishing it from sexually transmitted cases. [CDC 1, 2]
• Testicular torsion must be excluded, although it is less frequent in older men than in adolescents. [CDC 1, 2, 5]
• Lack of clinical improvement within 3 days warrants reevaluation for alternative diagnoses such as tumor, abscess, infarction, or testicular cancer. [CDC 1, 5]
• Atypical presentations are common in older adults, often manifesting as altered mental status, functional decline, or falls rather than classic scrotal pain. [European Association of Urology 6]
• Asymptomatic bacteriuria is highly prevalent in older men; detection of bacteria alone does not confirm infection and must be correlated with clinical findings. [European Association of Urology 6]

Etiology and Risk Factors for Epididymitis

Age‑Stratified Etiologic Framework

• In men younger than 35 years, sexually transmitted pathogens are the predominant cause of epididymitis, with Chlamydia trachomatis and Neisseria gonorrhoeae accounting for the majority of cases (CDC Recommendations) 7.
• In men older than 35 years, Gram‑negative enteric organisms—particularly Escherichia coli—are the primary pathogens (CDC Recommendations) 7.
• Sexually transmitted epididymitis in younger men is frequently accompanied by urethritis, which is often asymptomatic (CDC Recommendations) 7.

Risk Factors in Men > 35 Years

• Recent urinary‑tract instrumentation or surgery markedly increases the likelihood of enteric‑origin epididymitis (CDC Recommendations) 7.
• Anatomical abnormalities of the urinary tract (e.g., congenital malformations, obstruction) are associated with a higher risk of epididymitis (CDC Recommendations) 7.

Special Population Considerations

• Among men who have sex with men (MSM), insertive anal intercourse can lead to sexually transmitted E. coli infection of the epididymis, necessitating antimicrobial coverage for both typical sexually transmitted organisms and enteric bacteria (CDC Recommendations) 7.

Pediatric Associations

• In patients younger than 14 years, epididymitis is commonly linked to urinary‑tract infections and to structural or functional urinary‑tract abnormalities (American College of Radiology) 8.

Rare and Non‑Infectious Etiologies

• Tuberculous epididymitis should be considered when symptoms persist despite standard antibacterial therapy (CDC Recommendations) 9.
• Fungal epididymitis may occur, especially in immunocompromised individuals (CDC Recommendations) 9.

CDC Guidelines for Prevention and Management of Sexually‑Transmitted Epididymo‑orchitis and Testicular Atrophy

1. Epidemiology & Need for Screening

• Asymptomatic infection with Chlamydia trachomatis or Neisseria gonorrhoeae can progress to chronic epididymo‑orchitis and subsequent testicular atrophy if untreated. The CDC recommends vigilance for these pathogens in patients with scrotal inflammation. [10][11]12
• Asymptomatic chlamydial infection is common among sexually active adolescents and young adults; routine screening is advised even in the absence of symptoms. [11][12]13
• The majority of individuals infected with C. trachomatis or N. gonorrhoeae lack overt clinical signs; therefore, screening programs are essential rather than relying on symptom‑based diagnosis. [10][12]14

2. Antimicrobial Treatment Recommendations

2.1. Chlamydia

Strength of evidence: CDC categorizes these regimens as strong recommendation (Grade A) based on clinical trial data and systematic reviews.

2.2. Gonorrhea (and presumptive chlamydia coverage)

• Patients diagnosed with gonococcal infection should receive concurrent treatment for chlamydia because co‑infection rates are high. [10][11]15

• Recommended dual therapy for presumed gonococcal or chlamydial epididymo‑orchitis:

  • Ceftriaxone 250 mg intramuscular, single dose plus Doxycycline 100 mg orally, twice daily for 10 days. 16

• Strength of evidence: Strong recommendation (Grade A).

2.3. Enteric‑organism Epididymo‑orchitis (men ≥ 60 years or β‑lactam/tetracycline allergy)

• Ofloxacin 300 mg orally, twice daily for 10 days is advised for infections caused by gram‑negative enteric bacteria (e.g., E. coli). 16

• Strength of evidence: Moderate recommendation (Grade B).

2.4. Tuberculous or Fungal Epididymo‑orchitis (immunocompromised hosts)

• Consider tuberculous etiology when scrotal symptoms persist despite standard antibacterial therapy, especially in immunocompromised patients. 16
• Fungal epididymo‑orchitis may occur in patients with HIV, diabetes, or chronic immunosuppression and requires appropriate antifungal therapy. 16

3. Partner Management

• Sexual partners of patients with sexually transmitted epididymo‑orchitis must be notified, examined, and treated if sexual contact occurred within the 60 days preceding symptom onset. 16
• Patients should abstain from sexual activity until the full antimicrobial course is completed (≥ 7 days after a single‑dose regimen or after the end of a 7‑day regimen). [10][11]16

4. Follow‑up, Monitoring, and Adjunctive Care

• Lack of clinical improvement within 3 days of initiating therapy mandates reassessment for alternative diagnoses such as tumor, abscess, infarction, testicular cancer, or tuberculous/fungal epididymo‑orchitis. 16
• Persistent scrotal swelling or tenderness after completing antimicrobial therapy warrants comprehensive evaluation for residual infection or complications. 16
• Adjunctive measures for acute epididymo‑orchitis include bed rest, scrotal elevation, and analgesics until fever and local inflammation resolve. 16

5. Special Populations

• HIV‑infected individuals with epididymo‑orchitis should receive the same antimicrobial regimens as HIV‑negative patients; however, clinicians should maintain a higher index of suspicion for fungal and mycobacterial causes in this group. 16